Referred to the Committee on Appropriations, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
The Knock Out Cancer Act (H.R. 3873) seeks to increase funding for cancer research at the National Cancer Institute because cancer causes roughly one in four deaths in the United States and has claimed over 15 million American lives since 2000. The bill would provide additional annual appropriations equal to 25 percent of the National Cancer Institute's fiscal year 2022 budget for each year from 2026 through 2030, on top of its regular funding, based on the argument that research funding should be more proportional to cancer's mortality burden. The legislation also requires the FDA and Department of Health and Human Services to study why cancer drugs are in short supply and report their findings and recommendations to Congress within one year. The bill affects cancer patients, researchers, the pharmaceutical industry, and federal health agencies involved in drug development and approval. This legislation aims to accelerate medical breakthroughs in cancer treatment through substantially increased research investment.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.